Search Legislation

The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020

Changes over time for: PART 9

 Help about opening options

Alternative versions:

Changes to legislation:

There are currently no known outstanding effects for the The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, PART 9 . Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

PART 9 U.K.Amendment of Part 10 (amendment of Part 10 (exceptions to requirement for marketing authorisations etc))

102.  Before regulation 135 (amendment of regulation 168 (use of non-prescription medicines in the course of a business) insert—U.K.

New regulation 135ZA (amendment of regulation 167 (supply to fulfil special patient needs))

135ZA.  In regulation 167 (supply to fulfil special patient needs)—

(a)in paragraph (6), for “or imported into the United Kingdom from a country other than an EEA State” substitute “ , imported into Northern Ireland from a country other than an EEA State or Great Britain, or imported into Great Britain from a country other than an approved country for import or Northern Ireland ”;

(b)in paragraph (7)—

(i)for “imported from an EEA State” substitute “ imported into Northern Ireland from an EEA State or imported into Great Britain from a country other than an approved country for import ”;

(ii)for sub-paragraph (a) substitute—

(a)it is manufactured or assembled in that State or country (as appropriate) by a person who is the holder of an authorisation in relation to its manufacture or assembly in accordance with—

(i)in the case of a product for sale or supply in Northern Ireland, the provisions of the 2001 Directive as implemented in that State, and

(ii)in the case of a product for sale or supply in Great Britain, in accordance with the provisions applicable in that country; or;

(iii)for sub-paragraph (b) substitute—

(b)it is manufactured or assembled as an investigational medicinal product in that State or country (as appropriate) by the holder of an authorisation in relation to its manufacture or assembly in accordance with—

(i)in the case of a product for sale or supply in Northern Ireland, Article 13 of the Clinical Trials Directive as implemented in that State, and

(ii)in the case of a product for sale or supply in Great Britain, regulations 13 and 43 of the Clinical Trials Regulations,..

Commencement Information

I1Sch. 2 para. 102 in force at 31.12.2020 immediately before IP completion day, see reg. 1

103.  For regulation 135 (amendment of regulation 168 (use of non-prescription medicines in the course of a business)), substitute—U.K.

Amendment of regulation 168 (use of non-prescription medicines in the course of a business)

135.  In regulation 168 (use of non-prescription medicines in the course of a business), for paragraph (8) substitute—

(8) Condition G is that if the medicinal product is—

(a)manufactured or assembled in the United Kingdom or imported into the United Kingdom from—

(i)in the case of a product for sale or supply in Northern Ireland, a country other than an EEA State, or

(ii)in the case of a product for sale or supply in Great Britain, a country other than an approved country for import,

it is manufactured, assembled or imported by the holder of a manufacturer's licence that relates specifically to the manufacture, assembly or importation of special medicinal products, or

(b)imported into—

(i)Northern Ireland from an EEA State, it is manufactured or assembled in that State by a person who is the holder of an authorisation in relation to its manufacture or assembly in accordance with the provisions of the 2001 Directive as implemented in that State, or

(ii)Great Britain from an approved country for import—

(aa)it is manufactured or assembled in that country by a person who is the holder of an authorisation in that country in relation to its manufacture or assembly, and

(bb)it is imported by the holder of a wholesale dealer's licence under Part 3 that includes the import of a medicinal product from such a country...

Commencement Information

I2Sch. 2 para. 103 in force at 31.12.2020 immediately before IP completion day, see reg. 1

104.  In regulation 136 (amendment of regulation 169 (mixing of general sale medicinal products)), for “insert “ UK ” before “marketing authorisation” ” substitute “for “marketing authorisation” substitute “ UK marketing authorisation or EU marketing authorisation ””.U.K.

Commencement Information

I3Sch. 2 para. 104 in force at 31.12.2020 immediately before IP completion day, see reg. 1

105.  In regulation 137 (amendment of regulation 171 (exempt advanced therapy medicinal products)), for “substitute “regulation 49(1)”.” substitute—U.K.

substitute—

(i)in the case of a product for sale or supply in Northern Ireland, Regulation (EC) No 726/2004, and

(ii)in the case of a product for sale or supply in Great Britain, regulation 49(1)...

Commencement Information

I4Sch. 2 para. 105 in force at 31.12.2020 immediately before IP completion day, see reg. 1

106.  In regulation 138 (amendment of regulation 173 (exemption for certain radiopharmaceuticals)), for “insert “ UK ” before “marketing authorisation” ” substitute “for “marketing authorisation” substitute “ UK marketing authorisation or EU marketing authorisation ””.U.K.

Commencement Information

I5Sch. 2 para. 106 in force at 31.12.2020 immediately before IP completion day, see reg. 1

Back to top

Options/Help

Print Options

You have chosen to open The Whole Instrument

The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

You have chosen to open The Whole Instrument as a PDF

The Whole Instrument you have selected contains over 200 provisions and might take some time to download.

Would you like to continue?

You have chosen to open The Whole Schedule

The Whole Schedule you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

You have chosen to open The Whole Schedule as a PDF

The Whole Schedule you have selected contains over 200 provisions and might take some time to download.

Would you like to continue?

You have chosen to open the Whole Instrument

The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

You have chosen to open Schedules only

The Schedules you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

Explanatory Memorandum

Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as made version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources